T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$105B
| $2.32B | 0.58% |
18,080,405
-1,647,329
| -8% | -$202M |
|
27
Thermo Fisher Scientific
TMO
$223B
| $2.31B | 0.58% |
25,026,867
-946,410
| -4% | -$85.6M |
|
28
UnitedHealth
UNH
$367B
| $2.29B | 0.57% |
32,047,287
-447,493
| -1% | -$32M |
|
29
Johnson & Johnson
JNJ
$626B
| $2.26B | 0.56% |
26,035,293
-997,229
| -4% | -$89.5M |
|
30
PepsiCo
PEP
$188B
| $2.23B | 0.56% |
28,101,628
-626,020
| -2% | -$51.4M |
|
31
GE Aerospace
GE
$381B
| $2.23B | 0.56% |
19,504,383
-765,123
| -4% | -$87.7M |
|
|
CELG
32
DELISTED
Celgene Corp
CELG
| $2.21B | 0.55% |
28,680,426
+768,026
| +3% | +$53.8M |
|
33
Microsoft
MSFT
$3.74T
| $2.2B | 0.55% |
65,931,849
-854,701
| -1% | -$28.1M |
|
34
Merck
MRK
$322B
| $2.16B | 0.54% |
47,439,052
-3,037,082
| -6% | -$139M |
|
|
MRSH
35
Marsh
MRSH
$91.7B
| $2.15B | 0.54% |
49,290,691
+2,429,765
| +5% | +$102M |
|
36
Las Vegas Sands
LVS
$29.6B
| $2.07B | 0.52% |
31,137,138
+650,764
| +2% | +$37.7M |
|
37
Range Resources
RRC
$9.52B
| $2.01B | 0.5% |
26,502,476
+2,449,890
| +10% | +$191M |
|
38
Lowe's Companies
LOW
$124B
| $2B | 0.5% |
42,005,638
+2,109,971
| +5% | +$95.8M |
|
39
APA Corp
APA
$14.3B
| $1.99B | 0.5% |
23,341,403
+3,966,336
| +20% | +$329M |
|
40
Wells Fargo
WFC
$265B
| $1.92B | 0.48% |
46,502,298
-656,331
| -1% | -$28M |
|
41
AT&T
T
$168B
| $1.91B | 0.48% |
74,770,237
-5,775,565
| -7% | -$152M |
|
42
American Express
AXP
$230B
| $1.89B | 0.47% |
25,073,241
-2,573,036
| -9% | -$194M |
|
|
AMTD
43
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.89B | 0.47% |
72,005,182
-998,949
| -1% | -$26.5M |
|
44
Regeneron Pharmaceuticals
REGN
$82.8B
| $1.88B | 0.47% |
5,996,886
-330,003
| -5% | -$86.8M |
|
45
Invesco
IVZ
$13.9B
| $1.84B | 0.46% |
57,546,058
+479,349
| +0.8% | +$15.3M |
|
46
Home Depot
HD
$354B
| $1.82B | 0.46% |
24,041,421
+1,470,923
| +7% | +$114M |
|
47
State Street
STT
$51.4B
| $1.82B | 0.45% |
27,696,102
-296,822
| -1% | -$20.3M |
|
48
SLB Ltd
SLB
$79.4B
| $1.81B | 0.45% |
20,478,709
-1,845,285
| -8% | -$152M |
|
|
ALXN
49
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.8B | 0.45% |
15,523,852
-1,395,225
| -8% | -$153M |
|
50
Ecolab
ECL
$79.8B
| $1.79B | 0.45% |
18,128,248
+674,967
| +4% | +$62.8M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.